News and Analysis
Innovation, Technology, and IP News
Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...
The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma
Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...
Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says
Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...
FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications
Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...
Feed tagged as "appeal":
The legal battle between chipmaker Intel Corporation and patent holding company VLSI has taken another turn as the US Court of Appeals for ... Read More »
Tomorrow marks the release of our third annual CAFC Intelligence 2023 Report. This comprehensive report delves into the wealth of statistics and... Read More »
Patent litigation is a complex legal process that often involves disputes over intellectual property rights, particularly the validity and ... Read More »
The United States Court of Appeals for the Federal Circuit (CAFC) has been at the forefront of shaping patent law in the United States... Read More »
In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the ... Read More »
The Supreme Court is the highest court in the United States, and its decisions have a significant impact on the country's legal... Read More »
In late October, we released our second annual CAFC Intelligence Report. The report provided high-level statistics and insights and evaluated the... Read More »
There had been only two cases where damages over $2 billion have been awarded in a patent litigation case, in Pfizer vs Teva... Read More »
In 2019, Stephen Thaler filed two patent applications, 16/524,350 (teaching a “Neural Flame”) and 16/524,532... Read More »
Tomorrow we will release our 2022 CAFC Intelligence Report, where we have analyzed all the patent-related CAFC appeals from the USPTO, ITC, or... Read More »
When Apple and Qualcomm finally settled their dispute back in 2019, eyebrows were raised given that the licensing agreement had a six-year ... Read More »
This month we will publish our second annual CAFC Intelligence Report 2022, which covers the Court of Appeals for the Federal Circuit (CAFC). This... Read More »
An Avalanche of FWD Do-Overs Imminent?
Back in June I explained the latest constitutional challenge to AIA Trial Proceedings under the Appointments Clause of the... Read More »
